Pro-neurogenic effects of andrographolide on RSC96 Schwann cells in vitro

Autor: Jinmin Zhao, Kun Zhang, Fuben Xu, Li Zheng, Peizhen Lv, Huayu Wu
Rok vydání: 2016
Předmět:
0301 basic medicine
Cancer Research
Pathology
medicine.medical_specialty
Cell Survival
proliferation
Cell
Gene Expression
Schwann cell
S100 Calcium Binding Protein beta Subunit
Ciliary neurotrophic factor
Biochemistry
Cell Line
03 medical and health sciences
0302 clinical medicine
Neurotrophic factors
Genetics
medicine
Animals
Ciliary Neurotrophic Factor
RNA
Messenger

Viability assay
Molecular Biology
Cell Proliferation
biology
Cell growth
Brain-Derived Neurotrophic Factor
andrographolide
Articles
RSC96 Schwann cells
Rats
Neuroprotective Agents
030104 developmental biology
medicine.anatomical_structure
Oncology
Cell culture
peripheral nerve
Peripheral nerve injury
Cancer research
biology.protein
Molecular Medicine
Andrographis
Schwann Cells
Diterpenes
Corrigendum
030217 neurology & neurosurgery
Zdroj: Molecular Medicine Reports
ISSN: 1791-3004
1791-2997
DOI: 10.3892/mmr.2016.5717
Popis: Nerve regeneration remains a challenge to the treatment of peripheral nerve injury. Andrographolide (Andro) is the main active constituent of Andrographis paniculata, which has been applied in the treatment of several diseases, including inflammation, in ancient China. Andro has been reported to facilitate the reduction of edema and to exert analgesic effects in the treatment of various diseases. These findings suggest that Andro may be considered a promising anti-inflammatory agent that may suppress destruction and accelerate proliferation of Schwann cells following peripheral nerve injury. In the present study, the effects of Andro on RSC96 cells were investigated in vitro. The RSC96 cell line is a spontaneously immortalized rat Schwann cell line, which was originally derived from a long-term culture of rat primary Schwann cells. RSC96 cells were treated with a range of 0 to 50 µM Andro prior to the MTT assay. Cell proliferation, morphology, synthesis and nerve-specific gene expression were performed to detect the effect of Andro on RSC96 cells. The results of the present study demonstrated that the recommended doses of Andro ranged between 0.78 and 12.5 µM, among which the most obvious response was observed when used at 3.125 µM (P
Databáze: OpenAIRE